Bank Of America Corp Biocryst Pharmaceuticals Inc Call Options Transaction History

Bank Of America Corp

  • $1.19 Trillion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 12, 2023
BUY
$7.94 - $11.84 $178,650 - $266,400
22,500 New
22,500 $187,000
Q1 2022

May 16, 2022
BUY
$11.56 - $19.76 $92,480 - $158,080
8,000 Added 36.36%
30,000 $488,000
Q3 2021

Nov 15, 2021
SELL
$14.21 - $17.65 $397,880 - $494,199
-28,000 Reduced 56.0%
22,000 $316,000
Q2 2021

Sep 13, 2021
BUY
$9.5 - $17.24 $475,000 - $861,999
50,000 New
50,000 $790,000

Others Institutions Holding BCRX

# of Institutions
280
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.39B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email